Gene · 3713
NIH grants1,524
NIH grants whose papers are about the gene, through NIH's grant-paper links.
401 to 420 of 1,524
Download this page as JSON| Grant | Title | IVL papers | Newest fiscal year |
|---|---|---|---|
| F31DE030365 | Investigating the mechanism by which PTPN14 degradation by HPV E7 represses epithelial differentiation | 2 | 2021 |
| P50AR070590 | Psoriasis Center of Research Translation | 2 | 2021 |
| R01DE027185 | JARID1B-mediated epigenetic regulation of oncogenic signals in oral cancer | 2 | 2021 |
| T32AA013527 | Training in Neuroimmunoendocrine Effects of Alcohol | 2 | 2021 |
| DP5OD024587 | Biochemical Basis of Chromatin Folding and Chromosome Condensation | 1 | 2021 |
| F31CA236465 | Dissecting the role of serine metabolism in tumor initiating stem cells | 1 | 2021 |
| F99CA264315 | Epigenetic mechanisms regulate cancer development and tumor immune responses | 1 | 2021 |
| I01BX003453 | A novel treatment for bone fracture repair | 1 | 2021 |
| I01BX003814 | Vitamin D and Calcium signaling in epidermal stem cell maintenance, activation, and function | 1 | 2021 |
| K01AR072129 | Integrative Biology Approach to Identify and Characterize Roles of lncRNAs Associated with Psoriasis Pathology | 1 | 2021 |
| K01AR072773 | Breaking down barriers: defining the role of EphA2 in building epidermal tight junctions in atopic dermatitis | 1 | 2021 |
| K08CA215105 | Precision Medicine by Targeting Cell Adhesion in Melanoma | 1 | 2021 |
| P01CA210946 | RXR Rexinoids for Cancer Chemoprevention | 1 | 2021 |
| P01GM099117 | Dissecting the establishment and regulation of human pluripotency | 1 | 2021 |
| P01HL108808 | Development of Novel Mycolytic Therapies for Lung Disease | 1 | 2021 |
| P01HL132821 | Defining Molecular Phenotypes of Exacerbation Prone Asthmatics | 1 | 2021 |
| P41EB023833 | Center for Engineering Complex Tissues | 1 | 2021 |
| R00CA201603 | Recapitulating Ductal Carcinoma on a Chip for Personalized Breast Cancer Therapy | 1 | 2021 |
| R01AI065545 | Chlamydial invasion of non-phagocytic cells | 1 | 2021 |
| R01AI127783 | Hormones in allergic disease | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3713/grants?page=21